Myriad Genetics Inc
Symbol: MYGN (NASDAQ)
Company Description:
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.
- Today's Open: $0
- Today's High: $0
- Today's Low: $0
- Today's Volume: 0
- Yesterday Close: $5.07
- Yesterday High: $5.29
- Yesterday Low: $4.91
- Yesterday Volume: 1.99M
- Last Min Volume: 0
- Last Min High: $0
- Last Min Low: $0
- Last Min VWAP: $0
- Name: Myriad Genetics Inc
- Website: https://www.myriad.com
- Listed Date: 1995-10-06
- Location: SALT LAKE CITY, UT
- Market Status: Active
- CIK Number: 0000899923
- SIC Code: 2835
- SIC description: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
- Market Cap: $478.40M
- Round Lot: 100
- Outstanding Shares: 92.18M
- Asset Type: CS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-05 | 8-K | View |
| 2025-06-05 | S-8 | View |
| 2025-06-02 | 4 | View |
| 2025-05-15 | SCHEDULE 13G | View |
| 2025-05-12 | SCHEDULE 13G/A | View |
| 2025-05-07 | 10-Q | View |
| 2025-05-06 | 8-K | View |
| 2025-05-02 | 4 | View |
| 2025-05-01 | 3 | View |
| 2025-05-01 | 4 | View |
| 2025-05-01 | 4 | View |
| 2025-05-01 | S-8 | View |